At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
May 16, 2019
At Biogen, our mission is clear: we are pioneers in neuroscience.
Since our founding in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.
Our technology and engineering capabilities create novel ways to seamlessly transition products from development to manufacturing with the intent of bringing our high-quality medicines to market faster.
We respect the contributions of health care providers caring for people living with neurological diseases. We honor the important role of caregivers, families and friends who care about them.
Biogen is committed to working with advocacy and patient organizations as they serve the communities they represent.
Recognizing the challenges facing health care systems today, we collaborate with regulatory authorities and customers such as health care providers and payers, so that those in need can access our medicines.
Professional, ethical, and compliant, we hold ourselves accountable to deliver value to our shareholders.
Biogen contributes to the communities where we live. We are committed to our employees, diversity and inclusion, and environmental sustainability.
We care deeply about making a difference.
We work fearlessly. We do not give up even when challenged, pursuing innovation in all that we do.
We are humbled by the opportunity to change lives.
